HKG:1167

2 stories mentioning HKG:1167Updated 31d ago

Every FINWIRES story that references HKG:1167, newest first.

Jacobio Pharmaceuticals Launches HK$100 Million Share Buyback

Jacobio Pharmaceuticals (HKG:1167) plans to repurchase shares worth up to HK$100 million under a mandate approved by shareholders at its annual general meeting on June 5, according to a Monday Hong Kong bourse filing.The company is authorized to repurchase up to 78.4 million shares, representing 10% of its issued share capital, excluding treasury shares.Jacobio said the buybacks will be funded from internal resources and may continue until the mandate expires, subject to market conditions.

HKG:1167

Asia51d ago

Jacobio Pharmaceuticals Says Cash Runway Extends at Least Four Years

Jacobio Pharmaceuticals (HKG:1167) said its cash runway extends at least four years, supported by about 2.10 billion yuan in cash and bank balances, capital-protected structured deposits, and available bank credit facilities, according to a Tuesday Hong Kong bourse filing.The drug company said it has repurchased 747,800 shares for about HK$34.2 million as of May 18.Jacobio also received a $100 million upfront payment from AstraZeneca under a strategic collaboration agreement, along with 8.6 million yuan in sales royalty payments from Allist for the June-to-December 2025 period, the filing said.

HKG:1167

Track with the FINWIRES app suite

FolioX

Track HKG:1167 in your portfolio

WheelAI

Analyze HKG:1167 options with the wheel strategy

StockInsider

See market sentiment on HKG:1167